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Background: Combined pulmonary fibrosis and emphysema (CPFE) is characterized by both emphysema of the
upper zone and diffuse parenchymal lung disease with fibrosis of the lower zone of the lung on chest computed
tomography. The aim of this study was to investigate the mechanism of CPFE regarding gene expressions by
comparing the results of microarray sequences between fibrotic and emphysematous lesions in the lungs of CPFE
patients.
Results: The expression profiles of the fibrotic and emphysematous lesions were remarkably different in terms of
function. Genes related to the immune system, structural constituents of the cytoskeleton, and cellular adhesion
were overexpressed in fibrotic lesions, while genes associated with the cellular fraction, cell membrane structures,
vascular growth and biology, second-messenger-mediated signaling, and lung development (all processes that
contribute to the destruction and repair of cells, vessels, and the lung) were overexpressed in emphysematous
lesions.
Conclusions: The differences in gene expression were detected in fibrotic and emphysematous lesions in CPFE
patients. We propose that the development of coexisting fibrotic and emphysematous lesions in CPFE is
implemented by these different patterns of gene expressions.
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One of the most demonstrably clinical features of com-
bined pulmonary fibrosis and emphysema is that emphy-
sema of the upper zones and diffuse parenchymal lung
disease with fibrosis of the lower zones of the lungs are
both presented on chest computed tomography [1]. The
distinctive features of CPFE include cigarette smoking,
severe dyspnea, hypoxemia at exercise, subnormal spir-
ometry findings, and severely impaired lung diffusion
capacity [1,2]. Severe pulmonary hypertension is fre-
quently observed in CPFE, and is thought to determine
its prognosis [1,3]. The substantial pathogenesis of CPFE* Correspondence: masayuki@shinshu-u.ac.jp
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reproduction in any medium, provided the oris still unresolved because CPFE is not just one identical
phenotype of either idiopathic pulmonary fibrosis (IPF)
or emphysema [1,2]. Genetic factors have been shown to
play significant roles in the development of IPF. Fibrotic
lung specimens from patients with IPF exhibited misex-
pressions of genes encoding proteins probably involved
in the metabolism of the extracellular matrix (ECM),
chemokines, and tissue remodeling [4]. Genetic factors
are also believed to be associated with the pathogenesis
of emphysema. Lung tissues from patients with severe
emphysema displayed irregular expression of genes
involved in inflammation, the ECM, cytokines, chemo-
kines, apoptosis, and stress responses [5].
We hypothesized that coexistent fibrosis and emphy-
sema are programmed by differential gene expressionsal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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susceptible to CPFE. Given the importance of genetic
susceptibility in understanding the etiology and patho-
genesis of CPFE, we performed the whole-genome
microarray to sequence the gene expression profiling on
fibrotic and emphysematous tissues sampled from three
patients with CPFE to identify genes distinguishably
expressed in fibrotic lesions and emphysematous lesions
in lung tissues of patients with CPFE.
Results
Data deposition
The data reported in this paper have been deposited in
the Gene Expression Omnibus database [GEO:GSE38934].
Among all the specimens of lung tissue from the
resected lobes of the six patients (see Methods), six lung
specimens from three patients with CPFE (three speci-
mens from fibrotic lesions and three specimens from
emphysematous lesions) were selected to apply to the
current gene expression profiling study after confirming
the pathology in fibrotic lesions and emphysematous
lesions by H & E staining. Figures 1,2,3 show the chest
computed tomography and H & E staining microscopic
images for each case, representatively showing the upper
zone with emphysema, the lower zone with fibrosis, the








Figure 1 Chest computed tomography and H & E staining microscop
upper zone of the lung (a), fibrotic lesion at the lung base (b), and the can
(arrows) of sampling in the emphysematous lesion and the fibrotic lesion i
staining microscopic images of specimens of the emphysematous lesion (ecancerous lesions. All three patients were male ex-
smokers (smoking from 38 to 72 pack-years) aged from
60 to 78 years. The specimens of fibrotic lesions showed
usual interstitial pneumonia in histology, characterized
by fibroblastic foci and excessive deposition of the ECM
(Figures 1f,2f,3f ).
Summary of t test results, volcano plot and hierarchical
clustering analysis
Figure 4 presents the paired t test results summary as a
comparison between fibrotic and emphysematous lesions
on the microarray data (Figure 4a) and the volcano plot
as a representation of the point of intersection of the
fold-change (emphysema vs. fibrosis) relative to the P
value (emphysema vs. fibrosis) (Figure 4b). Hierarchical
clustering analysis was performed to build a heat map
(Figure 4c), which beautifully separated fibrotic and
emphysematous lesions into two clusters.
Gene functional classification for fibrotic lesions in CPFE
One hundred and forty genes with a signal log ratio
(SLR) cutoff of at least 1 were overexpressed in tissues
with fibrotic lesions versus emphysematous lesions
(Additional file 1: Table S1). When enrichment analysis
was applied to this set of genes, five functional annota-
tion clusters emerged (Figure 5); the most highlyc
f
Lung cancer
ic images for case 1. Upper panel: emphysematous change in the
cer shadow (arrow) at the right inferior lobe (c). Lower panel: positions
n the right inferior lobe without cancerous lesions (d), and the H & E
) and the fibrotic lesion (f).
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Figure 2 Chest computed tomography and H & E staining microscopic images for case 2. Upper panel: emphysematous change in the
upper zone of the lung (a), fibrotic lesion at the lung base (b), and the cancer shadow at the right inferior lobe (c). Lower panel: positions
(arrows) of sampling in the emphysematous lesion and the fibrotic lesion in the right inferior lobe without cancerous lesions (d), and the H & E
staining microscopic images of specimens of the emphysematous lesion (e) and the fibrotic lesion (f).
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cules with an enrichment score of 13.13. The other clus-
ters were based on annotations of immunoglobulin
heavy constant region (score of 5.57), immunoglobulin
variable region (score of 3.55), structural constituent of
cytoskeleton (score of 3.55), and cell adhesion (score of
2.94).
Gene functional classification for emphysematous lesions
in CPFE
After application of an analogous analysis process, 148
genes were identified as overexpressed in emphysema-
tous tissues relative to fibrotic tissues (Additional file 2:
Table S2). Of the six functional annotation clusters in
the emphysematous lesion dataset (Figure 6), the cellular
fraction cluster was the most enriched, with a score of
3.86. The other functional clusters were proteins in
structure of membrane (score of 2.47), regulation of
blood vessel (score of 2.36), angiogenesis and blood ves-
sel development (score of 1.85), second-messenger-
mediated signaling (score of 1.7), and lung development
(score of 1.65).
Discussion
The present study demonstrates in patients with CPFE
in which pulmonary fibrosis and emphysema coexisted
that the genes overexpressed in the fibrotic lesions werefunctionally different from those overexpressed in the
emphysematous lesions. The genes overexpressed in the
fibrotic lesions were annotated as contributing to func-
tions involving immunoglobulin, the structural constitu-
ents of the cytoskeleton, and cellular adhesion –
biological functions that are related to the pathophysi-
ology of fibrosis. The set of genes overexpressed in the
emphysematous lesions were annotated as associated
with cell membrane structures, vascular growth and
biology, second-messenger-mediated signaling, and lung
development – all processes that contribute to the de-
struction and repair of cells, vessels, and the lung. These
annotation-based clusters suggest that functionally dif-
ferent genes expressed in susceptible fields of the lungs
eventually contribute to the formation of either fibrosis
or emphysema, depending on the pattern of gene ex-
pression in that field.
The major finding of the present investigation is that
genes belonging to the clusters enriched for
immunoglobulin-like molecules, the immunoglobulin
constant region, and the immunoglobulin variable region
were markedly expressed in the fibrotic lesions. The
roles of autoimmunity in interstitial lung diseases (fibro-
sis in pathology) associated with connective tissue disor-
ders such as systemic sclerosis, systemic lupus
erythematosus, and rheumatoid arthritis are well estab-
lished [6]. Autoimmunity has been demonstrated to be
Sampling for emphysematous lesion





Figure 3 Chest computed tomography and H & E staining microscopic images for case 3. Upper panel: emphysematous change in the
upper zone of the lung (a), fibrotic lesion at the lung base (b), and the cancer shadow at the left superior lobe (c). Lower panel: positions
(arrows) of sampling in the emphysematous lesion and the fibrotic lesion in the left superior lobe without cancerous lesions (d), and the H & E
staining microscopic images of specimens of the emphysematous lesion (e) and the fibrotic lesion (f).
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IPF [6,7]; the presence of autoantibodies in the sera of
patients with IPF has been demonstrated elsewhere
[8,9]. Additionally, the initial hypothesis for the mechan-
ism of pulmonary fibrosis was that pulmonary inflamma-
tion was a prominent and necessary feature of the
fibrotic process [10]. Those genes involved with im-
munoglobulin were probably expressed by the inflamma-
tory cells in the infiltrates that were clearly presented in
the fibrotic tissues. However, to date no candidate genes
related to immunoglobulin-like molecules or members
of the immunity system annotation cluster have been
reported to be associated with lung fibrosis either in
case–control association studies [11,12] or in studies
based on human genome oligonucleotide microarrays
[13]. Our observations provide the first evidence of a
positive association of the immune system and pulmon-
ary fibrosis at the genetic level. This major finding fur-
ther supports the inflammation hypothesis of pulmonary
fibrosis [10,14].
Different from other findings in which the results of
gene expression in pulmonary fibrosis were resulted
from the comparisons of the gene expression datasetsbetween fibrous tissues and healthy lung tissues [13] or
hypersensitivity pneumonitis lung tissues [15], we found
that gene members of the structural constituent of cyto-
skeleton (keratin, claudin, dystonin) annotation cluster
were overexpressed in CPFE fibrotic lesions versus
emphysematous lesions. This observation provides gen-
etic evidence in support of the latest mechanism of pul-
monary fibrosis [16], which postulates that the losses of
epithelial cells, endothelial cells, and alveolar–capillary
barrier basement membrane integrity contribute to the
pathogenesis of pulmonary fibrosis. Furthermore, we
identified overexpression of the gene members of the
cell adhesion annotation cluster in the fibrosis lesions of
CPFE. Previously, cell adhesion molecules were shown
to be expressed in the lungs of patients with IPF [17].
Cell–cell and cell–ECM interactions are critical for the
pathogenesis of pulmonary fibrosis [18]. One of the es-
sential mechanisms by which cells interact with the
microenvironment is through the expression of cell ad-
hesion molecules [18]. Inflammatory cells may adhere to
and injure lung parenchymal cells through binding to
intercellular adhesion molecule 1. After initial injury, the
abnormalities in interepithelial adhesion interactions, the
Figure 4 Comparison of the signals between emphysematous and fibrotic lesions, fold-change and P value intersection, and
hierarchical clustering analysis. Paired t test results summary comparing between emphysematous and fibrotic lesions on the microarray data
(a), volcano plot representing the point of intersection of fold-change (FC) (emphysema vs. fibrosis) relative to P value (emphysema vs. fibrosis)
(b), and heat map built as the result of hierarchical clustering analysis (c). Emp 1_singal, Emp 2_singal, and Emp 3_singal indicate the signals
detected in the specimens of emphysematous lesions in case 1, case 2, and case 3, respectively. Fbr 1_singal, Fbr 2_singal, and Fbr 3_singal
indicate the signals detected in the specimens of fibrotic lesions in case 1, case 2, and case 3, respectively.
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and fibroblasts, and the disordered healing process even-
tually result in fibrosis [18].
Regarding the genes expressed in emphysematous
lesions in CPFE, our results showed that the genes
involved in cellular and membrane fractions, genes en-
coding proteins in membranes, genes related to blood
vessel size, development, and angiogenesis, and genes
related to second-messenger-mediated signaling were
overexpressed versus fibrotic lesions of CPFE. We
propose that the overexpression of genes with functions
contributing to the cellular fraction and membrane
structure may lead to the injury of pulmonary alveoli to
cause emphysema. In addition, our observation of the
overexpressed genes regulating blood vessel size, devel-
opment, and angiogenesis in the emphysematous lesionsin CPFE may explain the genetic susceptibility to high
prevalence (up to 47%) of pulmonary hypertension [1] in
CPFE. We suggest that the overexpression of these vas-
cular biology-related genes orchestrates the development
and progression of pulmonary hypertension in CPFE.
This hypertension may be a clinical characteristic that
distinguishes CPFE from severe emphysema without fi-
brosis; the latter has a lower frequency of pulmonary
hypertension than CPFE [1] and expresses downregu-
lated endothelium-related genes [5].
The main limitation of the present study is the very
small sample size, with only three patients with CPFE,
which occurred because lung tissue specimens were only
occasionally available following invasive operations for
other diseases; for example, lung cancer. Further study
with a larger sample size is necessary to confirm our
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Immunoglobulin like molecules
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Immunoglobulin constant region
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Immunoglobulin variable region
Annotation Cluster 4 
Enrichment Score: 3.55




Figure 5 Highly related genes and corresponding annotations in fibrotic lesions of combined pulmonary fibrosis and emphysema.
Two-dimensional view maps of the relationships between highly related genes and their corresponding annotations in fibrotic lesions of
combined pulmonary fibrosis and emphysema (CPFE) using the Gene Functional Classification Tool (http://david.abcc.ncifcrf.gov/gene2gene.jsp)
from the Database for Annotation, Visualization and Integrated Discovery (DAVID; http://david.abcc.ncifcrf.gov/home.jsp). Individual gene names
in the gene group are listed on the right-hand side of the map and functional annotation terms are presented on the lower side of the map.
Annotation cluster 1 for immunoglobulin-like molecules, annotation cluster 2 for immunoglobulin heavy constant region, annotation cluster 3 for
immunoglobulin variable region, annotation cluster 4 for structural constituent of cytoskeleton, and annotation cluster 5 for cell adhesion. Green
rectangle, corresponding gene-annotation association positively reported in DAVID; black rectangle, corresponding gene-annotation association
not yet reported in DAVID.
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results motivate a new direction for understanding the
coexistence of fibrosis and emphysema in CPFE.Conclusions
In summary, we have demonstrated that gene expression
differs between fibrotic and emphysematous lesions in
CPFE. In the fibrotic lesions, genes associated with the
immune system are highly expressed, while genes related
to the cellular fraction, membrane biology, and vascular
biology are highly expressed in emphysematous lesions.
We propose that the development of coexistent fibroticand emphysematous lesions in CPFE is implemented by
these different patterns of gene expression.
Methods
Patients and specimens
According to the characteristics of CPFE addressed by
Cottin and colleagues [1], six patients were selected for
the current study. All six patients were originally diag-
nosed with lung cancer and high-resolution computed
tomography showed not only the cancerous lesions but
also emphysematous lesions in the upper zones and fi-
brotic lesions in the lower zones. The fibrotic and
emphysematous lesions were located within the resected
Annotation Cluster 1  
Enrichment Score: 3.86 
Cellular fraction 
Annotation Cluster 3 
Enrichment Score: 2.36 
Regulation of blood vessel 
Annotation Cluster 4 
Enrichment Score: 1.85 
Angiogenesis and blood vessel development
Annotation Cluster 2 
Enrichment Score: 2.47 
Structural protein  membrane 
Annotation Cluster 5 
Enrichment Score: 1.7 
Signaling
Annotation Cluster 6 
Enrichment Score: 1.65 
Lung development
Figure 6 Highly related genes and corresponding annotations in emphysematous lesions of combined pulmonary fibrosis and
emphysema. Two-dimensional view maps of the relationships between highly related genes and their corresponding annotations in
emphysematous lesions of combined pulmonary fibrosis and emphysema (CPFE) using the Gene Functional Classification Tool (http://david.abcc.
ncifcrf.gov/gene2gene.jsp) from the Database for Annotation, Visualization and Integrated Discovery (DAVID; http://david.abcc.ncifcrf.gov/home.
jsp). Annotation cluster 1 for cellular fraction, annotation cluster 2 for proteins in structure of membrane, annotation cluster 3 for regulation of
blood vessel, annotation cluster 4 for angiogenesis and blood vessel development, annotation cluster 5 for signaling, and annotation cluster 6 for
lung development. Green rectangle, corresponding gene-annotation association positively reported in DAVID; black rectangle, corresponding
gene-annotation association not yet reported in DAVID.
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that impairment of carbon monoxide diffusing capacity
and subnormal spirometry were present in these
patients. CPFE was also diagnosed for these patients.
Lung lobectomy was thought to be the optimal treat-
ment for the lung cancer after consulting with chest sur-
geons. Specimens of fibrotic lesions and emphysematous
lesions in lung tissues were sampled from the resected
lobes of the six patients. Immediately after the lobec-
tomy, the lung tissues with fibrosis and emphysema were
separated from the resected lobes, and the lung tissue
adjacent to each specimen was cut for histological con-
firmation of the absence of cancerous cells. The patho-
logical types of fibrosis and emphysema were examined
and confirmed after H & E staining by a pathologist who
was blinded to the purpose of the study. This study was
approved by the Ethics Committee of Shinshu University
School of Medicine, and written informed consent was
obtained from all patients.
RNA isolation
Lung tissue specimens were immediately frozen in dry
ice and stored at −80°C. RNA was extracted from thelung tissues using TRIzol Reagent (Life Technologies,
Rockville, MD, USA) according to the manufacturer’s
protocol. RNA for microarray analysis was purified using
the RNeasy MinElute Cleanup Kit (QIAGEN, Valencia,
CA, USA) according to the manufacturer’s instructions.
RNA quality was assessed with an Agilent 2100 Bioana-
lyzer (Agilent Technologies, Palo Alto, CA, USA).
GeneChip expression preprocessing
In accordance with the standard Affymetrix protocol
from the GeneChip Expression Analysis Technical Man-
ual Revision 5 [19], 2 μg total RNA was processed, bioti-
nylated, fragmented, and hybridized to the GeneChip
Human Genome U133 Plus 2.0 Array (Affymetrix, Santa
Clara, CA, USA). The Human Genome U133 Plus 2.0
chips consist of 54,765 probe sets and provide compre-
hensive coverage of the transcribed human genome on a
single array, allowing the analysis of more than 47,000
transcripts and variants, including 38,500 well-
characterized human genes plus approximately 6,500
new genes [20]. Immediately following hybridization, the
probe array underwent an automated washing and stain-
ing protocol on the Affymetrix Fluidics Station 450. The
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metrix GeneChip Scanner 3000. Each probe array was
scanned twice and the software calculated an average of
the two images, defined the probe cells, and computed
the intensity for each cell. The double scan improved
assay sensitivity and reduced background noise. Each
complete probe array image was stored in a separate
data file.
Data processing
The scanned images were analysed with GeneChip Op-
erating Software version 1.4 (Affymetrix 690036) and
Microarray Suite version 5.0 (Affymetrix). The advan-
tages of the Microarray Suite include the associated P
values indicating statistical significance for detection and
change calls, the confidence limits being associated with
expression change values, and the negative expression
values being eliminated [21]. The profiling dataset from
the emphysematous lesions was used as background
when extracting the differentially expressed genes in the
fibrotic lesions, and the data from the fibrotic lesions
were used as background when extracting the differen-
tially expressed genes in the emphysematous lesions.
The trimmed mean target intensity of each array was set
to 500. Differentially expressed genes were extracted
using DNA Microarray Viewer (Kurabo, Osaka, Japan).
All microarray data of the individual lung tissue of the
six specimens are freely available through the Gene Ex-
pression Omnibus repository [GEO:GSE38934].
Data analysis
The paired t test was performed for comparison of the
detected signals between fibrotic and emphysematous
lesions on the microarray data. The volcano plot was
derived from the summary results of the paired t test to
represent the point of intersection of fold-change (em-
physema vs. fibrosis) relative to P value (emphysema vs.
fibrosis). Clustering analysis was then carried out with
log-transformed average signals of both fibrotic and
emphysematous lesions on the microarray data and the
heat map was built (Avadis 4.3; Strand Scientific
Intelligence, San Francisco, CA, USA), according to the
result of the hierarchical clustering analysis.
The SLR algorithm measures the magnitude and direc-
tion of the change between transcript levels of the ex-
perimental and background chips. A SLR of 1 represents
a twofold increase in the abundance of an mRNA, and a
value of −1 represents a twofold reduction in transcript
expression. In the present analysis, we extracted genes
with SLR >1 and SLR <1 for the fibrotic/emphysematous
and emphysematous/fibrotic ratios, respectively. We
then systematically annotated the large list of genes
according to their biological functions using bioinfor-
matics resources from the Database for Annotation,Visualization and Integrated Discovery [22], which pro-
vides the ability to explore and view functionally related
genes together, as a unit, to concentrate on the large bio-
logical network rather than at the level of an individual
gene [9]. Condensing large gene lists into biologically
meaningful modules greatly improves the ability to as-
similate large amounts of information and thus switches
functional annotation analysis from a gene-centric ana-
lysis to a biological module-centric analysis [9]. Since an
enrichment score of 1.3 is equivalent to 0.05 on the non-
log scale, we focused on gene clusters with scores ≥1.3
to address genes hypothetically involved in the pheno-
types of the examined tissues [9].
Additional file
Additional file 1: Table S1. One hundred and forty genes with signal
log ratio over 1 were overexpressed in lung tissues with fibrotic lesions
versus tissues with emphysematous lesions.
Additional file 2: Table S2. One hundred and forty eight genes with
signal log ratio less than 1 were overexpressed in lung tissues with
emphysematous lesions versus tissues with fibrotic lesions.
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